Edward Vranic, CFA
Contributor since: 2012
Company: Edward Vranic
Latest Articles
Aphria: The Aftermath Of Short Seller Accusations
AAOI's Road To Redemption Is Paved With Alibaba And Tencent's Chinese Data Center Arm's Race
MGX Minerals: CEO Jared Lazerson's First Revenue Forecast
MGX Minerals: Revenue Generation Imminent, Can Profits Be Far Behind?
Electrameccanica: Time To Transform Those $2 Billion Worth Of Electric Vehicle Pre-Orders Into Sales
Royal Nickel: A Spin Out Of Beta Hunt Might Be Warranted
New Age Beverages Is Not A Cannabis Play Yet But Is Up On Hype A Month After A $1.28 Financing
Black Box: Increasing Backlog Foretells A Turnaround In Revenues
Black Box: CEO Joel Trammell Is Making Bold, Promotional Statements In Interviews
MiMedx: A $400 Million Shell Trading Vehicle
Axovant Sciences: Expect A Crash After An Overhyped Deal With Oxford BioMedica
MGX Minerals: Reorganizing The Company To Maximize Shareholder Value
Viking Therapeutics: Sell The Pop On The Sympathy Play
Expect Red Robin Gourmet Burgers To Miss FY2018 EPS Guidance
The Market Is Rightfully Nervous Over MiMedx's Latest Bad News
Prothena: A Compelling Bounce Play To At Least $15 And Not Unrealistic Buyout Target
MiMedx: Taking A Deeper Look At The Stability Transaction
MiMedx Sinks After Conference Call, Marc Cohodes' Throwdown
MiMedx: Do The Numbers Support Channel Stuffing Accusations?
Short Sell Target: 7 Reasons To Expect Shutterfly To Drop Significantly In Price
Kodak And Overstock.Com: The Perfect Partnership To Take Advantage Of The Cryptohype
Selectcoin: Don't Invest In Bitcoin; Invest In Bitcoin Infrastructure
Nova Lifestyle Has A Fair Value Of $5 As Company Addresses Concerns
Urban FT Offers To Buy Digiliti: Is This A Creative Marketing Ploy?
Applied Optoelectronics' Road To $105: A Stock Buyback And A Short Squeeze
Prepare For More Dilution Of Inovio Pharmaceuticals
LightPath Technologies: Undervalued And Overlooked Small-Cap Player In A Hot Optical Components Industry
Real Goods Solar Is About To Collapse Under A Mountain Of Toxic Financing
GW Pharmaceuticals Executive Sells Shares Conveniently One Week After Buyout Rumor Pop
GW Pharmaceuticals' Buyout Rumor Appears Suspect: Liquidity Event For Recent Secondary?
Why Fossil Is On The Verge Of Collapse
Fossil: The Worst Is Yet To Come